Merck & Co. Inc
Merck & Co. Inc appears in FDA public data with 5 recalls, 0 510(k) clearances, 27 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0584-2025, Class II) was initiated on July 21, 2025.
Summary
- Total Recalls
- 5
- 510(k) Clearances
- 0
- Inspections
- 27
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0584-2025 | Class II | Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card con | July 21, 2025 |
| D-1310-2014 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/20 mg, a) 30 count blister (NDC 66582-321-30), | January 13, 2014 |
| D-1309-2014 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/10 mg, a) 30 count blister (NDC 66582-320-30), | January 13, 2014 |
| D-1312-2014 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/80 mg, a) 30 count blister (NDC 66582-323-30), | January 13, 2014 |
| D-1311-2014 | Class III | Liptruzet (ezetimibe and atorvastin) tablets,10 mg/40 mg, a) 30 count blister (NDC 66582-322-30), | January 13, 2014 |